Key result
Peripartum neuraxial anesthesia appears well tolerated in Ebstein anomaly deliveries with 0 deaths.
Why the study?
Peripartum anesthetic management can be challenging in patients with Ebstein anomaly due to high risk of cardiac failure and tachyarrhythmias, requiring appropriate risk stratification.
Is neuraxial anesthesia and analgesia safe for peripartum management in patients with Ebstein anomaly?
Case Report (n=9)
No
Is neuraxial anesthesia and analgesia safe for peripartum management in patients with Ebstein anomaly?
Neuraxial anesthesia and analgesia appear safe and well-tolerated for peripartum management in patients with Ebstein anomaly.
Supports consideration of neuraxial anesthesia in Ebstein anomaly deliveries; leaves open prospective validation before broader adoption.
Ebstein anomaly is a rare congenital cardiac condition associated with displacement and incompetence of the tricuspid valve. Peripartum anesthetic management can be particularly challenging since these patients are at high risk of cardiac failure and tachyarrhythmias. Risk stratification is important since it helps to identify high-risk patients who should deliver at a tertiary care center where a multidisciplinary team (obstetrics, cardiology, anesthesiology, and neonatology) is immediately available. We describe the peripartum anesthetic management of 9 patients with Ebstein anomaly who underwent 12 deliveries at our institution. All patients tolerated neuraxial anesthesia and analgesia well. No maternal or fetal deaths occurred.
No takes yet. Share an insight, caveat, or question.
Gurrieri et al. (2023) conducted a case report in Ebstein anomaly (n=9). Neuraxial anesthesia and analgesia was evaluated on Maternal or fetal deaths.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: